世界の一次進行型多発性硬化症の治療市場2019

• 英文タイトル：Global Primary Progressive Multiple Sclerosis Treatment Sales Market Report 2019

• レポートコード：QYR9N3747
• 出版社/出版日：QYResearch / 2019年6月13日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、一次進行型多発性硬化症の治療の世界市場について調査・分析し、一次進行型多発性硬化症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・一次進行型多発性硬化症の治療市場概要
・一次進行型多発性硬化症の治療のメーカー別販売量・メーカー別シェア
・一次進行型多発性硬化症の治療の種類別販売量（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、その他）
・一次進行型多発性硬化症の治療の用途別販売量（病院、診療所、その他）
・一次進行型多発性硬化症の治療の地域別販売量・市場シェア
・一次進行型多発性硬化症の治療の米国市場規模（2014年-2019年）
・一次進行型多発性硬化症の治療のヨーロッパ市場規模（2014年-2019年）
・一次進行型多発性硬化症の治療の中国市場規模（2014年-2019年）
・一次進行型多発性硬化症の治療の日本市場規模（2014年-2019年）
・一次進行型多発性硬化症の治療の東南アジア市場規模（2014年-2019年）
・一次進行型多発性硬化症の治療のインド市場規模（2014年-2019年）
・一次進行型多発性硬化症の治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・一次進行型多発性硬化症の治療のコスト分析
・一次進行型多発性硬化症の治療販売チャネル、流通業者、顧客
・一次進行型多発性硬化症の治療の世界市場動向・機会・成長要因・課題
・一次進行型多発性硬化症の治療の種類別世界市場予測（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、その他）
・一次進行型多発性硬化症の治療の用途別世界市場予測（病院、診療所、その他）
・一次進行型多発性硬化症の治療の米国市場予測（2019年-2025年）
・一次進行型多発性硬化症の治療のヨーロッパ市場予測（2019年-2025年）
・一次進行型多発性硬化症の治療の中国市場予測（2019年-2025年）
・一次進行型多発性硬化症の治療の日本市場予測（2019年-2025年）
・一次進行型多発性硬化症の治療の東南アジア市場予測（2019年-2025年）
・一次進行型多発性硬化症の治療のインド市場予測（2019年-2025年）
...

The global Primary Progressive Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Primary Progressive Multiple Sclerosis Treatment market status and forecast, categorizes the global Primary Progressive Multiple Sclerosis Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Glialogix, Inc.
Kyorin Pharmaceutical Co., Ltd.
MedDay SA
Santhera Pharmaceuticals Holding AG
Teva Pharmaceutical Industries Ltd.
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
ApE
Biotin
GZ-402668
Ibudilast
Idebenone
Laquinimod Sodium
Others

Segment by Application
Hospital
Clinic
Others

レポート目次

Table of Contents

Global Primary Progressive Multiple Sclerosis Treatment Sales Market Report 2019
1 Primary Progressive Multiple Sclerosis Treatment Market Overview
1.1 Primary Progressive Multiple Sclerosis TreatmentProduct Overview
1.2 Primary Progressive Multiple Sclerosis Treatment Segment by Type
1.2.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Comparison by Types (2014-2025)
1.2.2 ApE
1.2.3 Biotin
1.2.4 GZ-402668
1.2.5 Ibudilast
1.2.6 Idebenone
1.2.7 Laquinimod Sodium
1.2.8 Others
1.3 Primary Progressive Multiple Sclerosis Treatment Segment by Application
1.3.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Comparison by Application (2014-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Primary Progressive Multiple Sclerosis Treatment Market by Region
1.4.1 Global Primary Progressive Multiple Sclerosis Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Primary Progressive Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.3 Europe Primary Progressive Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.4 China Primary Progressive Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.5 Japan Primary Progressive Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.4.7 India Primary Progressive Multiple Sclerosis Treatment Status and Prospect (2014-2025)
1.5 Global Primary Progressive Multiple Sclerosis Treatment Sales and Revenue (2014-2025)
1.5.1 Global Primary Progressive Multiple Sclerosis Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue and Growth Rate (2014-2025)

2 Primary Progressive Multiple Sclerosis Treatment by Company, Region, Type and Application
2.1 Global Primary Progressive Multiple Sclerosis Treatment Market Competition by Companies
2.1.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Primary Progressive Multiple Sclerosis Treatment Sales and Revenue by Region
2.2.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Primary Progressive Multiple Sclerosis Treatment Sales and Revenue by Type
2.3.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Primary Progressive Multiple Sclerosis Treatment Sales by Application

3 United States Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price
3.1 United States Primary Progressive Multiple Sclerosis Treatment Sales and Revenue (2014-2019)
3.1.1 United States Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Primary Progressive Multiple Sclerosis Treatment Price Trend (2014-2019)
3.2 United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company
3.3 United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type
3.4 United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application

4 Europe Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price
4.1 Europe Primary Progressive Multiple Sclerosis Treatment Sales and Value (2014-2019)
4.1.1 Europe Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Primary Progressive Multiple Sclerosis Treatment Price Trend (2014-2019)
4.2 Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company
4.3 Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type
4.4 Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application

5 China Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price
5.1 China Primary Progressive Multiple Sclerosis Treatment Sales and Revenue (2014-2019)
5.1.1 China Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
5.1.2 China Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Primary Progressive Multiple Sclerosis Treatment Price Trend (2014-2019)
5.2 China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company
5.3 China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type
5.4 China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application

6 Japan Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price
6.1 Japan Primary Progressive Multiple Sclerosis Treatment Sales and Value (2014-2019)
6.1.1 Japan Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Primary Progressive Multiple Sclerosis Treatment Price Trend (2014-2019)
6.2 Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company
6.3 Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type
6.4 Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application

7 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price
7.1 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Price Trend (2014-2019)
7.2 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company
7.3 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type
7.4 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application

8 India Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price
8.1 India Primary Progressive Multiple Sclerosis Treatment Sales and Value (2014-2019)
8.1.1 India Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
8.1.2 India Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Primary Progressive Multiple Sclerosis Treatment Price Trend (2014-2019)
8.2 India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company
8.3 India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type
8.4 India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Primary Progressive Multiple Sclerosis Treatment Business
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
9.1.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.1.3 F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Genzyme Corporation
9.2.1 Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
9.2.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.2.3 Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Glialogix, Inc.
9.3.1 Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
9.3.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.3.3 Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Kyorin Pharmaceutical Co., Ltd.
9.4.1 Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
9.4.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.4.3 Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 MedDay SA
9.5.1 MedDay SA Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
9.5.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.5.3 MedDay SA Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Santhera Pharmaceuticals Holding AG
9.6.1 Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
9.6.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.6.3 Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Teva Pharmaceutical Industries Ltd.
9.7.1 Teva Pharmaceutical Industries Ltd. Production Sites and Area Served
9.7.2 Primary Progressive Multiple Sclerosis Treatment Specification and Application
9.7.3 Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
…

10 Primary Progressive Multiple Sclerosis Treatment Maufacturing Cost Analysis
10.1 Primary Progressive Multiple Sclerosis Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Primary Progressive Multiple Sclerosis Treatment
10.4 Primary Progressive Multiple Sclerosis Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Primary Progressive Multiple Sclerosis Treatment Distributors List
11.3 Primary Progressive Multiple Sclerosis Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Primary Progressive Multiple Sclerosis Treatment Market Forecast
13.1 Global Primary Progressive Multiple Sclerosis Treatment Sales, Revenue and Price Forecast
13.1.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Primary Progressive Multiple Sclerosis Treatment Price Trend Forecast (2019-2025)
13.2 Global Primary Progressive Multiple Sclerosis Treatment Forecast by Region
13.2.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Primary Progressive Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Primary Progressive Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Primary Progressive Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Primary Progressive Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Primary Progressive Multiple Sclerosis Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Primary Progressive Multiple Sclerosis Treatment Forecast by Type
13.3.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Primary Progressive Multiple Sclerosis Treatment Price Forecast by Type (2019-2025)
13.4 Global Primary Progressive Multiple Sclerosis Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: Primary Progressive Multiple Sclerosis Treatment Sales (Jan)
Figure Primary Progressive Multiple Sclerosis Treatment Product Picture
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Types in 2018
Figure ApE Product Picture
Figure Biotin Product Picture
Figure GZ-402668 Product Picture
Figure Ibudilast Product Picture
Figure Idebenone Product Picture
Figure Laquinimod Sodium Product Picture
Figure Others Product Picture
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Primary Progressive Multiple Sclerosis Treatment by Application in 2018
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Table Global Market Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Growth Rate (2014-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) of Key Companies (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales by Company in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Share by Company (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Share by Company in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) by Company in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue Share by Company (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue Share by Company in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Market Share by Region (2014-2019)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Share by Region (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Share by Region in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue Share by Region (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share by Region In 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Share by Type (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate by Type in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue Share by Type (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue Growth Rate by Type in 2018
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Share by Application (2014-2019)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure United States Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table United States Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table United States Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table United States Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure United States Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure Europe Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure China Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure China Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table China Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table China Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table China Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure China Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure Japan Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table Japan Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table Japan Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table Japan Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Figure India Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate (2014-2019)
Figure India Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Trend (2014-2019)
Table India Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Company (2014-2019)
Table India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company (2014-2019)
Figure India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Company in 2018
Table India Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Type (2014-2019)
Table India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type (2014-2019)
Figure India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Type in 2018
Table India Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) by Application (2014-2019)
Table India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application (2014-2019)
Figure India Primary Progressive Multiple Sclerosis Treatment Sales Market Share by Application in 2018
Table F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table MedDay SA Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table MedDay SA Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table MedDay SA Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure MedDay SA Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure MedDay SA Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure MedDay SA Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served
Table Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Specification and Application
Table Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Growth Rate (2014-2019)
Figure Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Revenue Share in International Market (2014-2019)
Figure Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Progressive Multiple Sclerosis Treatment
Figure Manufacturing Process Analysis of Primary Progressive Multiple Sclerosis Treatment
Figure Primary Progressive Multiple Sclerosis Treatment Industrial Chain Analysis
Table Primary Progressive Multiple Sclerosis Treatment Distributors List
Table Primary Progressive Multiple Sclerosis Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share Forecast by Regions in 2025
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Primary Progressive Multiple Sclerosis Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global Primary Progressive Multiple Sclerosis Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global Primary Progressive Multiple Sclerosis Treatment Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の進行性再発性多発性硬化症治療市場2019

Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Report 2019
QYR9N3775 2019年6月13日 106Pages
本調査レポートでは、進行性再発性多発性硬化症治療の世界市場について調査・分析し、進行性再発性多発性硬化症治療のメーカー別販売量、市場シェア分析、種類別販売分析（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別販売分析（診療所、Hopital、その他）、地域別販売...

世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測

Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2019-2025
QYR9N7888 2019年6月14日 94Pages
当資料は、進行性多巣性白質脳症治療のグローバル市場について調査・分析したレポートで、種類別（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状）、用途別（病院薬局、ドラッグストア、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...

世界の多発性骨髄腫の治療市場：市場規模・現状・予測

Global Multiple Myeloma Treatment Market Size, Status and Forecast 2019-2025
QYR9N7601 2019年6月14日 94Pages
当資料は、多発性骨髄腫の治療のグローバル市場について調査・分析したレポートで、種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本...

世界のマルチスピンドルヘッド市場2019

Global Multiple Spindle Heads Sales Market Report 2019
QYR9N2768 2019年6月10日 100Pages
本調査レポートでは、マルチスピンドルヘッドの世界市場について調査・分析し、マルチスピンドルヘッドのメーカー別販売量、市場シェア分析、種類別販売分析（2スピンドルヘッド、3スピンドルヘッド、4スピンドルヘッド、その他）、用途別販売分析（建設、工業用、自動車、その他）、地域別販売分析（米国、ヨーロッパ、...

世界の多周波バイオインピーダンスデバイス市場2019

Global Multiple-frequency Bioimpedance Devicess Sales Market Report 2019
QYR9N2769 2019年6月10日 118Pages
本調査レポートでは、多周波バイオインピーダンスデバイスの世界市場について調査・分析し、多周波バイオインピーダンスデバイスのメーカー別販売量、市場シェア分析、種類別販売分析（有線バイオインピーダンスデバイス、ワイヤレスバイオインピーダンスデバイス）、用途別販売分析（病院、診療所、リハビリテーションセン...

世界の複数通貨偽造紙幣探知機市場2019

Global Multiple Currency Counterfeit Detector Sales Market Report 2019
QYR9N2767 2019年6月10日 127Pages
本調査レポートでは、複数通貨偽造紙幣探知機の世界市場について調査・分析し、複数通貨偽造紙幣探知機のメーカー別販売量、市場シェア分析、種類別販売分析（コンパクトタイプ、中型タイプ、大型タイプ）、用途別販売分析（小売、ホテル、銀行業、ギャンブル、輸送、その他）、地域別販売分析（米国、ヨーロッパ、中国、日...

世界の腱炎治療市場：市場規模・現状・予測

Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
QYR9N8111 2019年6月14日 93Pages
当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・腱炎治療...

世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測

Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
QYR9N7541 2019年6月14日 94Pages
当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界のディンプル形成術の治療市場：市場規模・現状・予測

Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
QYR9N7109 2019年6月14日 93Pages
当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のフォンヴィレブランド病治療市場：市場規模・現状・予測

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N8188 2019年6月14日 93Pages
当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の進行性再発性多発性硬化症治療市場2019 The global Progressive Relapsing Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Progressive Relapsing Multiple Sclerosis Treatment market status and forecast, c…
世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測 Progressive multifocal leukoencephalopathy is a rare but debilitating and frequently fatal viral disease of the central nervous system, primarily affecting individuals with chronically and severely suppressed immune systems.Growing prevalence of HIV is expected to drive the growth of the progressive…
世界の多発性骨髄腫の治療市場：市場規模・現状・予測 Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
世界のマルチスピンドルヘッド市場2019 The global Multiple Spindle Heads market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Multiple Spindle Heads market status and forecast, categorizes the global Multiple Spindle Heads market size…
世界の多周波バイオインピーダンスデバイス市場2019 The global Multiple-frequency Bioimpedance Devicess market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies the global Multiple-frequency Bioimpedance Devicess market status and forecast, categorizes…